HSD17B13 Inhibitors are Hepatoprotective and Anti-inflammatory in a Mouse Model of Autoimmune Hepatitis
Final Data of the Phase 2a INTREPID Study with EDP-305, a Non-Bile Acid Farnesoid X Receptor (FXR) Agonist